Janney Montgomery Scott Starts ProQR Therapeutics N.V. (PRQR) at Neutral
- Netflix, Inc. (NFLX) Tops Q4 EPS by 1c; Subs Beat Views
- S&P 500 ends up slightly with boost from financials; Netflix up late
- Nestle Said Examining Takeover of Mead Johnson (MJN) - Source
- Fed's Yellen says 'makes sense' to gradually raise interest rates
- UPDATE: Fed Beige Book: Wages gain modestly in most areas amid tight job market
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Janney Montgomery Scott initiated coverage on ProQR Therapeutics N.V. (NASDAQ: PRQR) with a Neutral rating and a price target of $7.00.
Shares of ProQR Therapeutics N.V. closed at $7.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Oppenheimer Starts Fortive (FTV) at Perform
- Miller Tabak Starts Expedia (EXPE) at Strong Buy
- Miller Tabak Starts TripAdvisor (TRIP) at Hold
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesJanney Montgomery Scott
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!